Vascular Access

Publication Date: March 1, 2020
Last Updated: January 31, 2023

GUIDELINE STATEMENTS

Patient First: ESKD Life-Plan

ESKD Life-Plan and Vascular Access Choice

KDOQI considers it reasonable that each patient with progressive CKD and/or with an eGFR 15-20 mL/min/1.73 m2 or already on kidney replacement therapy should have an individualized ESKD Life-Plan that is regularly reviewed, updated, and documented on their medical record. (Expert Opinion)
317606

Overview

Title

Vascular Access

Authoring Organization